Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07860710 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

J-LINX: Japan LINerixibat eXtension Study

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
GlaxoSmithKline
246 trials monitored
See 20 trials at risk
This study evaluates the long-term safety and tolerability of linerixibat in Japanese adults with cholestatic pruritus in primary biliary cholangitis (PBC) who previously participated in the linerixibat long-term safety and efficacy study, LLSAT (NCT04167358). Participants will continue receiving linerixibat while researchers monitor adverse events and other safety measures to better understand the long-term safety of treatment and provide continued access to therapy.
Trial Details
NCT Number NCT07860710
Lead Sponsor GlaxoSmithKline
Conditions
(from sponsor)		 Pruritus
Related terms Liver Cirrhosis, Biliary, Pruritus
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov